LONSURF

This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Netherlands, Poland, Romania, Singapore, United Kingdom, United States

Active ingredients

The drug LONSURF contains a combination of these active pharmaceutical ingredients (APIs):

1 Trifluridine UNII RMW9V5RW38 - TRIFLURIDINE

Read about Trifluridine

2 Tipiracil UNII 4H59KLQ0A4 - TIPIRACIL HYDROCHLORIDE

Tipiracil helps maintain the blood concentration of trifluridine by inhibiting the enzyme thymidine phosphorylase which metabolizes trifluridine. Read about Tipiracil

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L01BC59		L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01B Antimetabolites → L01BC Pyrimidine analogues
Discover more medicines within L01BC59

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 11507P, 11524M, 12033H, 12056M
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 531320090011107, 531320090011207, 531320090011307, 531320090011407
Country: CA	Health Products and Food Branch	Identifier(s): 02472104, 02472112
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 5189-MEE-0620, 5190-MEE-0620
Country: EE	Ravimiamet	Identifier(s): 1716319, 1716320, 1716331, 1716342, 1716353, 1716364
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 1161096001, 1161096003, 1161096004, 1161096006
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 057979, 158698, 389330, 516182
Country: FR	Base de données publique des médicaments	Identifier(s): 65185956, 69681469
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 329756, 329757, 329761, 329762
Country: HK	Department of Health Drug Office	Identifier(s): 65360, 65361
Country: IE	Health Products Regulatory Authority	Identifier(s): 88850, 88851, 88852, 88853
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 8802, 8803
Country: IT	Agenzia del Farmaco	Identifier(s): 044856019, 044856021, 044856033, 044856045, 044856058, 044856060
Country: JP	医薬品医療機器総合機構	Identifier(s): 4299100F1026, 4299100F2022
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1080198, 1080199, 1080200, 1080201, 1080202, 1080203
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 137510, 137529
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100370700, 100370716
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W63841001, W63841002, W63842001, W63842002
Country: SG	Health Sciences Authority	Identifier(s): 15491P, 15494P
Country: US	FDA, National Drug Code	Identifier(s): 64842-1020, 64842-1025